Docality.com Logo
 
Dr. Lorie  Loreman  Do image

Dr. Lorie Loreman Do

334 W 10Th Pl Ste 100
Mesa AZ 85201
480 340-0771
Medical School: Philadelphia College Of Osteopathic Medicine - 1987
Accepts Medicare: Yes
Participates In eRX: Yes
Participates In PQRS: Yes
Participates In EHR: Yes
License #: 3782
NPI: 1285612291
Taxonomy Codes:
207RP1001X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Dr. Lorie Loreman is associated with these group practices

Procedure Pricing

HCPCS Code Description Average Price Average Price
Allowed By Medicare
HCPCS Code:31628 Description:Bronchoscopy/lung bx each Average Price:$550.00 Average Price Allowed
By Medicare:
$189.31
HCPCS Code:31622 Description:Dx bronchoscope/wash Average Price:$360.00 Average Price Allowed
By Medicare:
$146.98
HCPCS Code:99291 Description:Critical care first hour Average Price:$320.00 Average Price Allowed
By Medicare:
$216.18
HCPCS Code:99222 Description:Initial hospital care Average Price:$210.00 Average Price Allowed
By Medicare:
$132.39
HCPCS Code:94060 Description:Evaluation of wheezing Average Price:$85.00 Average Price Allowed
By Medicare:
$12.52
HCPCS Code:99223 Description:Initial hospital care Average Price:$260.00 Average Price Allowed
By Medicare:
$194.33
HCPCS Code:99205 Description:Office/outpatient visit new Average Price:$230.00 Average Price Allowed
By Medicare:
$197.79
HCPCS Code:99204 Description:Office/outpatient visit new Average Price:$185.00 Average Price Allowed
By Medicare:
$159.23
HCPCS Code:94060 Description:Evaluation of wheezing Average Price:$85.00 Average Price Allowed
By Medicare:
$59.81
HCPCS Code:94726 Description:Pulm funct tst plethysmograp Average Price:$75.00 Average Price Allowed
By Medicare:
$52.83
HCPCS Code:99215 Description:Office/outpatient visit est Average Price:$160.00 Average Price Allowed
By Medicare:
$138.42
HCPCS Code:99233 Description:Subsequent hospital care Average Price:$120.00 Average Price Allowed
By Medicare:
$99.52
HCPCS Code:99214 Description:Office/outpatient visit est Average Price:$120.00 Average Price Allowed
By Medicare:
$103.11
HCPCS Code:99232 Description:Subsequent hospital care Average Price:$85.00 Average Price Allowed
By Medicare:
$69.38
HCPCS Code:94727 Description:Pulm function test by gas Average Price:$55.00 Average Price Allowed
By Medicare:
$41.50
HCPCS Code:94729 Description:C02/membane diffuse capacity Average Price:$65.00 Average Price Allowed
By Medicare:
$52.42
HCPCS Code:99406 Description:Behav chng smoking 3-10 min Average Price:$25.00 Average Price Allowed
By Medicare:
$13.51
HCPCS Code:99211 Description:Office/outpatient visit est Average Price:$30.00 Average Price Allowed
By Medicare:
$19.45
HCPCS Code:J7644 Description:Ipratropium bromide non-comp Average Price:$5.00 Average Price Allowed
By Medicare:
$0.26

HCPCS Code Definitions

99233
Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is unstable or has developed a significant complication or a significant new problem. Typically, 35 minutes are spent at the bedside and on the patient's hospital floor or unit.
99406
Smoking and tobacco use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes
99214
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent face-to-face with the patient and/or family.
99211
Office or other outpatient visit for the evaluation and management of an established patient, that may not require the presence of a physician or other qualified health care professional. Usually, the presenting problem(s) are minimal. Typically, 5 minutes are spent performing or supervising these services.
99222
Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of moderate severity. Typically, 50 minutes are spent at the bedside and on the patient's hospital floor or unit.
94726
Plethysmography for determination of lung volumes and, when performed, airway resistance
94060
Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration
31628
Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with transbronchial lung biopsy(s), single lobe
94060
Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration
99204
Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 45 minutes are spent face-to-face with the patient and/or family.
94727
Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes
94729
Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)
99205
Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 60 minutes are spent face-to-face with the patient and/or family.
99215
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 40 minutes are spent face-to-face with the patient and/or family.
99223
Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of high severity. Typically, 70 minutes are spent at the bedside and on the patient's hospital floor or unit.
J7644
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
99232
Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is responding inadequately to therapy or has developed a minor complication. Typically, 25 minutes are spent at the bedside and on the patient's hospital floor or unit.
31622
Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; diagnostic, with cell washing, when performed (separate procedure)
99291
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

NPI
Doctor Name
Specialty
Count
1255379442
Cardiovascular Disease (Cardiology)
2,131
1548224447
Medical Oncology
1,944
1003866278
Internal Medicine
1,803
1316995699
Hematology
1,680
1790757706
Diagnostic Radiology
1,570
1104890854
Internal Medicine
1,527
1487610499
Internal Medicine
1,125
1528030525
Diagnostic Radiology
1,037
1033112818
Nephrology
900
1376523902
Gastroenterology
870
*These referrals represent the top 10 that Dr. Loreman has made to other doctors

Publications

Code 100: a study on suicidal behavior in public places. - Actas españolas de psiquiatría
Every day, the emergency departments in our country receive a large number of patients that have thought about or attempted suicide. Unfortunately, these patients are very often reluctant to maintain a regular follow-up in mental health services. In this study we describe an original program to encourage assessment and treatment of suicidal patients, particularly when they receive medical treatment in public places. We summarize the application of the program and compare the results of a specific follow-up between two groups of patients: suicidal patients assessed by emergency services in public places and all other suicidal patients assessed in the emergency department of a tertiary hospital.
The expression of epidermal lipoxygenases and transglutaminase-1 is perturbed by NIPAL4 mutations: indications of a common metabolic pathway essential for skin barrier homeostasis. - The Journal of investigative dermatology
Autosomal recessive congenital ichthyosis (ARCI) is a heterogeneous group of skin barrier diseases due inter alia to mutations in transglutaminase-1 (TGM1), in lipoxygenases (LOXs) of the hepoxilin pathway, and in ichthyin, a putative Mg(2+) transporter encoded by the NIPAL4 gene. In search of a common pathogenic pathway for ARCI, we investigated the epidermal expression of TGM1, 12R-LOX, eLOX-3, and ichthyin in skin biopsies from four healthy controls and nine patients with ARCI. In healthy skin, TGM1, ichthyin, and the LOX enzymes were predominantly expressed in the upper epidermis where colocalization signals could also be demonstrated by in situ proximity ligation assay. In patients with ALOX12B mutations and abnormal 12R-LOX expression, the colocalization signal for eLOX-3 and TGM1 was increased 4-fold. In contrast, patients with NIPAL4 mutations and abnormal ichthyin expression showed increased 12R-LOX and eLOX-3 staining and a colocalization signal of these LOXs that was three times the normal intensity. Treatment of these patients with a retinoid-mimetic drug, liarozole, normalized the expression of 12R-LOX and attenuated the colocalization signal. Altogether, our data indicate that ichthyin and TGM1 are functionally closely related in the lipid processing and that this metabolic pathway can be modified by retinoids.
Characterization of immortalized human epidermolysis bullosa simplex (KRT5) cell lines: trimethylamine N-oxide protects the keratin cytoskeleton against disruptive stress condition. - Journal of dermatological science
Epidermolysis bullosa simplex (EBS) is an autosomal inherited mechano-bullous disease, characterized by intraepidermal blistering and skin fragility caused by mutations in the keratin (KRT) 5 or 14 genes. Despite a vast knowledge about the intermediate filament pathology in this disease, the progress in therapy has been slow. Animal models and well-characterized continuous cell culture models of EBS are needed prior to clinical testing.Our aim was to generate immortalized cell lines as an in vitro model for the study of EBS and test a chemical chaperone, trimethylamine N-oxide (TMAO), as a putative novel therapy.We generated four immortalized cell lines, two each from an EBS patient with a KRT5-mutation (V186L) and a healthy control, using human papillomavirus 16 (HPV16) E6E7 as transducer. Cell lines were established in serum-free and serum-containing medium and assessed for growth characteristics, keratin expression profiles, ability to differentiate in organotypic cultures, and response to heat stress with and without the presence of TMAO.All cell lines have been expanded >160 population doublings and their cellular characteristics are similar. However, the formation of cytoplasmic keratin filament aggregates in response to heat-shock treatment differed between EBS and normal cell lines. Notably, serum-free established EBS-cell line was most vulnerable to heat shock but both cell lines exhibited significant reduction in the number of keratin aggregates containing cells by TMAO.The immortalized cell lines represent a suitable model for studying novel therapies for EBS. TMAO is a promising new agent for future development as a novel EBS therapy.
Expression level of lipoprotein lipase and dystrophin genes predict survival in B-cell chronic lymphocytic leukemia. - Leukemia & lymphoma
Mutational status of immunoglobulin variable region genes (VH-genes) is known as the strongest predictor of long term prognosis in B-CLL. However, applications in the routine clinical practice are time consuming, and therefore some other predictions are required. In this study, we have compared prognostic values of real time PCR quantification of the expression levels of four genes previously shown to be differentially expressed in V(H)-unmutated and mutated B-CLL subtypes: ZAP-70, ZBTB20, DMD and LPL. The study included 134 B-CLL patients. Expression levels of LPL and DMD genes were significantly correlated to mutational status, while expression levels of of ZAP-70 gene correlated only in CD19+ selected cases (N = 40). No correlation was observed for ZBTB20 gene. Expression levels of LPL and DMD predicted overall survival in the entire cohort of patients. Prognostic values of LPL gene expression levels were significant even for CLL patients with stage A. Quantitative RT-PCR assays for measuring LPL gene expression are robust enough to be introduced into routine clinical practice.
Myelodysplastic syndromes with isolated deletion of the long arm of the chromosome X as a sole cytogenetic change. - Cancer genetics and cytogenetics
Deletions of Xq are extremely rare events in myelodysplastic syndromes (MDS) patients and were previously described in five patients, in two of them as a sole chromosome abnormality. We found isolated del(Xq) in 3 of 127 MDS patients with clonal chromosome changes. Detailed analysis of clinical and morphological data of presented and previously published cases indicates the following: (1) del(X)(q24) and del(X)(q13) are nonrandom chromosomal abnormalities in MDS; (2) MDS with deletions of Xq affect exclusively females ages 46-65; and (3) deletions of Xq are associated with refractory anemia with excess blasts (RAEB) and indicate an unfavorable prognosis.
The use of magnetic resonance imaging in the diagnosis and followup of pediatric pelvic rhabdomyosarcoma. - The Journal of urology
Previous radiological descriptions of pelvic rhabdomyosarcoma emphasized ultrasonography and computerized tomography (CT). Few reports are available on the use of magnetic resonance imaging (MRI) for diagnosing and following pelvic rhabdomyosarcoma. We retrospectively compared MRI to CT for diagnosing and following children with pelvic rhabdomyosarcoma.We treated 4 boys and 3 girls for pelvic rhabdomyosarcoma. Initial and followup evaluations included pelvic CT and MRI at intervals determined by treatment and disease status. We retrospectively reviewed the clinical charts and imaging studies of these patients. The initial radiological report was evaluated and then 1 radiologist reviewed all studies. Attention was directed toward identifying lesions revealed by CT or MRI but not by the other modality.MRI detected all lesions shown by CT. On the other hand, MRI detected residual disease in 1 case that was not demonstrated by CT. In 2 other patients MRI was superior to CT for delineating the local extent of disease, especially urethral involvement.Compared with CT, MRI improves the detection of residual pelvic rhabdomyosarcoma. Tissue planes are well delineated, allowing more accurate assessment of tumor invasion into adjacent structures. MRI is the imaging modality of choice for following pediatric patients with pelvic rhabdomyosarcoma.
Formative design of a virtual learning environment. - Studies in health technology and informatics
Current technology for 3D visualization, modeling and interaction allows the construction of attractive virtual environments for study of anatomy, surgery and other biomedical fields. The formative methodology for designing such environments is uncharted, but necessary before committing to large scale development. We present one such methodology undertaken during the design of a learning environment for biology for high school and middle school students. We expect to extend this design methodology to the development of environments for the teaching of medical subjects.
[Hydrogen test: its diagnostic possibilities in intestinal diseases]. - Klinicheskaia meditsina
The determination of hydrogen in exhaled air by gas chromatography was used for investigation of patients with relapsing diarrhea of various genesis. An increased H level on an empty stomach, regarded as a sign of bacterial growth in the intestine, was detected in 45% of examines, mainly in celiac disease immunodeficiency, intestinal tuberculosis, diverticulosis, diabetic enteropathy, and erosive duodenitis. An increase in the H level in exhaled air after a lactose tolerance test (50 g of lactose) made it possible to diagnose lactose deficiency in 38% of patients with chronic relapsing diarrhea. In the irritable colon syndrome lactose deficiency was detected in 40% of patients.
[Gastrointestinal biorhythms in chronic intestinal diseases]. - Sovetskaia meditsina
Gastric and intestinal bio-electrical activity (BEA) was assessed from body surface by means of a modified electrogastrograph, EGS-4M, in 387 patients with various intestinal conditions and 39 normal subjects. The method is simple, atraumatic and rather inexpensive. It revealed qualitative and quantitative BEA changes (uncoordination in half the cases, and increased amplitudes of waveforms I, IV and V) in patients with mild disorders, which were chiefly functional and involved no organic gastro-intestinal lesions (i.e., signs of gastric or colonic irritation). In cases of chronic small-intestinal conditions, involving impaired absorption syndrome, reduced waveform II and III amplitudes showed correlation to the severity of the latter. BEA normalization in the course of treatment provides an objective indicator of the degree of patient rehabilitation and the efficiency of treatment at large. BEA parameters cannot be used for nosologic or differential diagnosis. BEA measurements, combined with other techniques, can be useful for the assessment of motor/evacuatory activity of the digestive system.
Multiple epiphyseal dysplasia complicated by severe osteochondritis dissecans of the knee. Incidence in two families. - Skeletal radiology
Two families are described which appear to contain examples of multiple epiphyseal dysplasia. In both families a striking incidence of severe osteochondritis of the knees was encountered. It is suggested that this was caused by the fragmented and maldeveloped epiphyses characteristic of epiphyseal dysplasia.

Map & Directions

334 W 10Th Pl Ste 100 Mesa, AZ 85201
View Directions In Google Maps

Nearby Doctors

570 W Brown Rd
Mesa, AZ 85201
480 442-2007
570 W Brown Rd
Mesa, AZ 85201
480 442-2028
266 W 3Rd Pl Suite 1
Mesa, AZ 85201
480 351-1174
1025 N Country Club Dr
Mesa, AZ 85201
480 724-4856
570 W Brown Rd
Mesa, AZ 85201
480 442-2007
570 W Brown Rd
Mesa, AZ 85201
602 442-2002
1705 W Main St
Mesa, AZ 85201
877 095-5092
570 W Brown Rd
Mesa, AZ 85201
480 442-2002
303 N Centennial Way
Mesa, AZ 85201
480 493-3111
1025 N Country Club Dr
Mesa, AZ 85201
480 087-7245